These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 355737)

  • 61. Fructose improves the ability of hyperglycemia per se to regulate glucose production in type 2 diabetes.
    Hawkins M; Gabriely I; Wozniak R; Vilcu C; Shamoon H; Rossetti L
    Diabetes; 2002 Mar; 51(3):606-14. PubMed ID: 11872657
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Somatostatin in maturity-onset diabetes.
    Christensen SE; Hansen AP; Lundbaek K
    Diabetes; 1978 Oct; 27(10):1013-9. PubMed ID: 700257
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Evidence for an important role of glucagon in the regulation of hepatic glucose production in normal man.
    Liljenquist JE; Mueller GL; Cherrington AD; Keller U; Chiasson J-L ; Perry JM; Lacy WW; Rabinowitz D
    J Clin Invest; 1977 Feb; 59(2):369-74. PubMed ID: 833282
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Evolving role of glucagon in human diabetes mellitus.
    Eaton RP
    Diabetes; 1975 May; 24(5):523-4. PubMed ID: 1092584
    [No Abstract]   [Full Text] [Related]  

  • 65. Insulin-dependent diabetes mellitus. Sudden onset following hypophysectomy in an acromegalic patient.
    Bunick EM; Schmidek H; Lavine RL; Garofano CD; Rose LI
    JAMA; 1977 Sep; 238(10):1047-8. PubMed ID: 577945
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Glucagon and diabetes: a reappraisal.
    Lefebvre PJ; Luyckx AS
    Diabetologia; 1979 Jun; 16(6):347-54. PubMed ID: 381082
    [No Abstract]   [Full Text] [Related]  

  • 67. Diabetes mellitus secondary to chronic pancreatitis.
    Larsen S
    Dan Med Bull; 1993 Apr; 40(2):153-62. PubMed ID: 8495594
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of glucagon on glucose production during insulin deficiency in the dog.
    Cherrington AD; Lacy WW; Chiasson JL
    J Clin Invest; 1978 Sep; 62(3):664-77. PubMed ID: 690190
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of insulin replacement on intermediary metabolism in diabetes secondary to pancreatectomy.
    Del Prato S; Tiengo A; Baccaglini U; Tremolada C; Duner E; Marescotti MC; Avogaro A; Valverde I; Nosadini R; Assan R
    Diabetologia; 1983 Sep; 25(3):252-9. PubMed ID: 6357912
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Abnormal response of pancreatic glucagon to glycemic changes in diabetes mellitus.
    Ohneda A; Watanabe K; Horigome K; Sakai T; Kai Y; Oikawa S
    J Clin Endocrinol Metab; 1978 Mar; 46(3):504-10. PubMed ID: 752036
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Role of hyperglucagonemia in catabolism associated with type 1 diabetes: effects on leucine metabolism and the resting metabolic rate.
    Charlton MR; Nair KS
    Diabetes; 1998 Nov; 47(11):1748-56. PubMed ID: 9792544
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Extrapancreatic glucagon in control of glucose turnover in depancreatized dogs.
    Ross G; Lickley L; Vranic M
    Am J Physiol; 1978 Feb; 234(2):E213-19. PubMed ID: 623297
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Somatostatin modulation of glucagon secretion and its importance in human glucose homeostasis.
    Gerich JE
    Metabolism; 1978 Sep; 27(9 Suppl 1):1283-90. PubMed ID: 682992
    [No Abstract]   [Full Text] [Related]  

  • 74. The role of glucagon deficiency in the Houssay phenomenon of dogs.
    Nakabayashi H; Dobbs RE; Unger RH
    J Clin Invest; 1978 May; 61(5):1355-62. PubMed ID: 659597
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Failre of suppress plasma glucagon concentrations by orally administered glucose in diabetic patients after treatment.
    Seino Y; Ikeda M; Kurahachi H; Taminato T; Sakurai H; Goto Y; Inoue Y; Kadowaki S; Mori K; Imura H
    Diabetes; 1978 Dec; 27(12):1145-50. PubMed ID: 363490
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Hyperglycemia per se (insulin and glucagon withdrawn) can inhibit hepatic glucose production in man.
    Liljenquist JE; Mueller GL; Cherrington AD; Perry JM; Rabinowitz D
    J Clin Endocrinol Metab; 1979 Jan; 48(1):171-5. PubMed ID: 422700
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The contribution of hyperglycemic hormones to the pathogenesis of diabetes mellitus.
    Sperling MA
    Am J Dis Child; 1977 Oct; 131(10):1145-9. PubMed ID: 910769
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Glucagon physiology and pathophysiology in the light of new advances.
    Unger RH
    Diabetologia; 1985 Aug; 28(8):574-8. PubMed ID: 3902546
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Insulin secretory capacity and the regulation of glucagon secretion in diabetic and non-diabetic alcoholic cirrhotic patients.
    Kruszynska YT; Goulas S; Wollen N; McIntyre N
    J Hepatol; 1998 Feb; 28(2):280-91. PubMed ID: 9514541
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Is glucagon important in stable insulin-dependent diabetics?
    Barnes AJ; Bloom A; Crowley MF; Tuttlebee JW; Bloom SR; Alberti KG; Smythe P; Turnell D
    Lancet; 1975 Oct; 2(7938):734-7. PubMed ID: 52770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.